Loading clinical trials...
Loading clinical trials...
As a novel ultra-short-acting benzodiazepines drugs, Remimazolam has been accepted for induction and maintenance of clinical anesthesia. Compared to the traditional benzodiazepines drugs, Remimazolam ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Second Affiliated Hospital of Nanchang University
NCT07152912 · Isoflurane, Sevoflurane, and more
NCT07050212 · Remimazolam, Dexmedetomidine, and more
NCT07046364 · Pediatric, Neurosurgery, and more
NCT06716840 · Remimazolam, Propofol, and more
NCT05891145 · Coronary Artery Bypass Grafting, Remimazolam
the Second Affiliated Hospital of Nanchang University, Nanchang University
Nanchang, Jiangxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions